# Immunovant, Inc.: Form 8-K, filed Nov 12, 2020

- Company: [Immunovant, Inc.](/companies/imvt.md) (CIK 1764013)
- Form: 8-K
- Filed: 2020-11-12
- Accepted by EDGAR: Nov 12, 2020, 08:28 ET
- Period: 2020-11-09
- Accession: 0001764013-20-000062
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1764013/000176401320000062/imvt-20200930x8xk.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1764013/000176401320000062/

## Items reported

- Item 2.02: Results of operations

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1764013/000176401320000062/imvt-20200930x8xk.htm

Filed Nov 12, 2020.
Source: SEC EDGAR, the filing index for accession 0001764013-20-000062. Last ingested by Listed: Nov 13, 2026, 16:26 ET. No prices; not investment advice.
